Presented at American Society for Microbiology (ASM) Microbe 2025, a process improvement project led by Navarathna et al at Central Texas Veterans Health Care System evaluated the impact of incorporating enzyme immunoassays (EIAs) into existing polymerase chain reaction (PCR)–based diagnostic protocols for Clostridioides difficile infection (CDI).
The study compared 2 EIA platforms against PCR results and found that EIAs were less than 30% as sensitive as PCR. Of 13 health care–onset CDI (HO-CDI) cases identified during the project, only 3 were confirmed by EIA. Interestingly, 5 inpatients who had positive PCR results but did not meet testing criteria had positive EIA results, indicating potential active infection. Lower PCR cycle threshold values, indicating higher bacterial loads, were significantly associated with EIA positivity, reinforcing the concept that EIAs require a higher level of toxin for detection.